Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618
Trial:
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Helios Klinikum Berlin-Buch

Schwanebecker Chaussee     13125
Berlin ,
Germany

 

Principal Investigator:
Peter Reichardt, MD
Contact:
Activation Status of this Site:
Not yet activated
Notes about this Site:
Helios Klinikum Berlin-Buch Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.